September 10, 2021, St. Louis, USA — For his research in biomedicine that has led to valuable revelations about the nature of disease and preventative care during the COVID-19 crisis, Dr. Chee Sian Kuan of Malaysia has been selected as a 2021 JCI Ten Outstanding Young Persons of the World (JCI TOYP) Honoree in the category of Medical Innovation.
Dr. Kuan obtained his Bachelor of Health Science and Doctor of Philosophy at the University of Science Malaysia, where he made the dean’s list and graduated with honors. His doctoral study focused on human ethanolamine and choline kinase – proteins that play a key role in phospholipid metabolism and are involved in cancer pathways. Dr. Kuan’s research work has been presented and shared with the scientific community in many conferences and webinars. One of his works on genome analysis of Bipolaris papendorfii was awarded with the Best Poster Presentation Award at the Infections 2015 Conference.
Throughout his career, Dr. Kuan has developed various molecular diagnostic platforms for illnesses and continues to evaluate the most effective models for treatment. His areas of expertise include syndromic panel-based testing, genetic panels that can influence predictive medicine, precision medicine, and personalized medicine, among others. His works are widely published in international peer-reviewed journals and cited by many. This information serves as a guide for medical practitioners and laboratory operators in selecting the most suitable technique for diagnostic purposes.
In 2016, Kuan founded NeoGenix Laboratoire, a laboratory providing the highest quality molecular diagnostic tests. NeoGenix was selected as one of only five companies in Malaysia to sign an MoU with the BD Summit in Doha, Qatar as collaborative partner for the healthcare sector in the Middle East.
NeoGenix was awarded by the Ministry of Health in Malaysia for providing Covid-19 PCR tests to 59 government hospitals in Malaysia during the early stage of the pandemic in 2020. Kuan also led the team that provided the first PCR tests from a private laboratory in the country. NeoGenix has recently landed a contract with Pure Health Medical Supplies L.L.C. to screen all travelers from Malaysia to the United Arab Emirates for Covid-19. The lab is currently working with the Johor state government to help with Covid-19 screening and assisting with plans to reopen the Malaysia-Singapore border. NeoGenix is collaborating with MaRii and RZAC ImmuneSAFE Sdn Bhd to provide antibody testing to assist people in making informed clinical decisions about their health and help verify the effectiveness of vaccine protection.
About JCI TOYP: JCI (Junior Chamber International) honors ten outstanding young people under the age of 40 each year. These individuals exemplify the spirit of the JCI Mission and have extraordinary accomplishments regarding individual development, business and entrepreneurship, community action and international cooperation. Whether through service, innovation, determination or revolutionary thinking, these young leaders create beneficial solutions on a local and global level.
The ten honorees will be recognized at the 2021 JCI Awards Ceremony at the 2021 JCI World Congress in November.
About JCI: JCI, a global leadership organization, provides personal and professional development opportunities to young leaders age 18 to 40. Through its international network of around 110 countries, JCI unites all sectors of society and empowers the leaders of tomorrow to turn challenges into opportunities today. For more information, visit juniorchamber.international.